Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
2.
Rev Med Interne ; 40(12): 785-790, 2019 Dec.
Article in French | MEDLINE | ID: mdl-31668883

ABSTRACT

INTRODUCTION: Hodgkin's lymphoma (HL) is less common than non-Hodgkin lymphoma and is rarely associated with autoimmune cytopenia. METHOD: We report a consecutive, monocentric and retrospective series of HL patients diagnosed with concomitant or subsequent autoimmune cytopenia over a period of 8 years. RESULTS: We report 4 out of 84 HL patients (4.8%) diagnosed with autoimmune cytopenia (4 immune thrombocytopenia including 2 Evans' syndromes). They were 4 males (average age 24 years for the 3 youngest, and one over 60 years old). Autoimmune cytopenia revealed lymphoma in 2 patients and occurred after HL treatment in the two other patients (5 and 36 months from the end of chemotherapy) without HL relapse. All cytopenias were resistant to conventional treatments (glucocorticoids, intravenous immune globulin, rituximab) and sensitive to chemotherapy when indicated for HL treatment. CONCLUSION: In our series, the predominance of males, a higher frequency of immune thrombocytopenia than autoimmune hemolytic anemia, the resistance to usual treatments and the efficacy of specific chemotherapy were consistent with the literature. Unexpectedly, patients were young and with nodular sclerosis morphology (vs. mixed cellularity) in 3 of 4 cases.


Subject(s)
Anemia, Hemolytic, Autoimmune/complications , Anemia, Hemolytic, Autoimmune/diagnosis , Hodgkin Disease/complications , Hodgkin Disease/diagnosis , Purpura, Thrombocytopenic, Idiopathic/complications , Purpura, Thrombocytopenic, Idiopathic/diagnosis , Adolescent , Adult , Aged , Humans , Male , Retrospective Studies , Thrombocytopenia/complications , Thrombocytopenia/diagnosis , Young Adult
3.
Bull Soc Pathol Exot ; 109(4): 281-286, 2016 Oct.
Article in French | MEDLINE | ID: mdl-26850104

ABSTRACT

The Healthcare Workers Treatment Center of Conakry, Guinea, was inaugurated in january 2015. It is dedicated to the diagnosis and the treatment of healthcare workers with probable or confirmed Ebola viral disease. It is staffed by the french army medical service. The french military team may reconcile their medical practice and the ethno-cultural imperatives to optimise the patient adherence during his hospitalization.


Subject(s)
Health Personnel , Hemorrhagic Fever, Ebola/therapy , Infectious Disease Transmission, Patient-to-Professional , Occupational Diseases/therapy , Adult , Attitude of Health Personnel , Continuity of Patient Care , Culture , Female , Guinea/epidemiology , Health Personnel/psychology , Health Personnel/statistics & numerical data , Hemorrhagic Fever, Ebola/epidemiology , Hemorrhagic Fever, Ebola/psychology , Humans , Infectious Disease Transmission, Patient-to-Professional/statistics & numerical data , Male , Occupational Diseases/epidemiology , Physician-Patient Relations , Protective Clothing , Retrospective Studies
4.
Clin Microbiol Infect ; 20(1): O7-12, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23826912

ABSTRACT

The aim of our study was to determine the epidemiological profile and the antibiotic susceptibility of bacteria and fungi identified from blood cultures in the patients of the clinical haematology unit. A retrospective study was carried out over an 8-year period (2003-2010) in the clinical haematology unit of the Percy Military Medical Center. During this period, we collected 723 isolates: Gram-negative bacilli (70.8%) and Gram-positive cocci (18.7%). The four most commonly isolated species were Escherichia coli (18.5%), Pseudomonas aeruginosa (14.8%), Stenotrophomonas maltophilia (6.2%) and Staphylococcus epidermidis (5.4%). The rate of methicillin-resistant Staphylococcus aureus was 6.45% and that of coagulase-negative staphylococci 61.2%. No resistance to glycopeptides was observed. In E. coli, as in the Klebsiella-Enterobacter-Serratia group, a 27% resistance to fluoroquinolones was observed. Concerning P. aeruginosa, the phenotypes were distributed over penicillinase (23.4%) and cephalosporinase (13.1% were resistant to ceftazidime). The impermeability rate of imipenem was 9.3%. The aggressiveness and duration of haematological treatments explains why infections remain one of the main complications of neutropenia. The emergence of new or unusual bacteria is highly likely. Antibiotic selective pressure and long periods of hospitalization could explain the emergence of multiresistant bacteria. As a consequence, epidemiological surveillance is indispensable.


Subject(s)
Bacteremia/microbiology , Blood/microbiology , Febrile Neutropenia/microbiology , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Anti-Bacterial Agents/pharmacology , Bacteremia/epidemiology , Drug Resistance, Bacterial , Epidemiological Monitoring , Febrile Neutropenia/epidemiology , Gram-Negative Bacteria/classification , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/classification , Gram-Positive Bacteria/drug effects , Hospitals, Military/statistics & numerical data , Humans , Microbial Sensitivity Tests , Retrospective Studies
5.
Ann Hematol ; 91(12): 1871-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22820971

ABSTRACT

Current salvage therapies for relapsed acute myeloid leukemia (AML) are unsatisfactory. We retrospectively evaluated the efficacy and toxicity of fractionated doses of gemtuzumab ozogamicin (GO) combined with a standard 3 + 7 induction regimen in young patients with AML in first relapse. Salvage regimen consisted of GO 3 mg/m² on days 1, 4, and 7; cytarabine, 200 mg/m² on days 1-7; and daunorubicine, 60 mg/m²; or idarubicine, 12 mg/m² on days 1-3. Fourteen patients were treated between April 2008 and April 2011. Median age was 46 years (29-58), median white blood cell count is 3.4 109/L (0.9-19), and median first complete remission (CR) duration is 11 months (1-42). All the patients had previously received high or intermediate doses of cytarabine as consolidation therapy. Salvage treatment was performed as scheduled for the 14 patients, using daunorubicine in 12 patients and idarubicine in two. Overall response rate was 79 % with six CR and five CR with incomplete platelet recovery. Median times to neutrophil (>0.5 109/L) and platelet (>20 109/L) recovery were 29 days (23-32) and 36 days (28-48), respectively. Allogeneic transplantation was performed in the 11 responding patients within a median time of 4 months (3-10). Three mild and one moderate veno-occlusive disease (VOD) occurred after salvage and two moderate VOD after transplantation. Median and 2-year overall survival (OS) were 10 months and 42 %, respectively. For responders, estimated 2-year OS was 53 % (median OS not reached). This salvage regimen seems safe and effective in younger patients with AML in first relapse allowing allogeneic transplantation in CR2 for most patients.


Subject(s)
Aminoglycosides/administration & dosage , Antibodies, Monoclonal, Humanized/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Induction Chemotherapy , Leukemia, Myeloid, Acute/drug therapy , Salvage Therapy , Adult , Aminoglycosides/adverse effects , Aminoglycosides/therapeutic use , Antibodies, Monoclonal, Humanized/adverse effects , Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Combined Modality Therapy , Cytarabine/administration & dosage , Cytarabine/adverse effects , Cytarabine/therapeutic use , Daunorubicin/administration & dosage , Daunorubicin/adverse effects , Daunorubicin/therapeutic use , Drug Administration Schedule , Female , Follow-Up Studies , Gemtuzumab , Hematopoietic Stem Cell Transplantation/adverse effects , Hepatic Veno-Occlusive Disease/chemically induced , Hepatic Veno-Occlusive Disease/etiology , Hepatic Veno-Occlusive Disease/physiopathology , Hepatic Veno-Occlusive Disease/prevention & control , Humans , Idarubicin/administration & dosage , Idarubicin/adverse effects , Idarubicin/therapeutic use , Induction Chemotherapy/adverse effects , Leukemia, Myeloid, Acute/therapy , Male , Middle Aged , Recurrence , Retrospective Studies , Salvage Therapy/adverse effects , Severity of Illness Index , Survival Analysis
6.
Pathol Biol (Paris) ; 59(3): 146-50, 2011 Jun.
Article in French | MEDLINE | ID: mdl-19477606

ABSTRACT

UNLABELLED: The monitoring of infection by glycopeptide-resistant enterococci (GRE) is one of the main elements of hospital hygiene policy. It involves systematic rectal swabs in clinics at risk (asymptomatic carriage). AIM: We compare two GRE screening methods and evaluate a new kit associating multiplex PCR and hybridization (Génotype(®) Enterococcus, Hain Lifescience) on a panel of 448 samples collected over a 4-month period. PATIENTS AND METHODS: The first method is based on direct inoculation of the sample; the second one involves a preliminary enrichment phase followed by molecular diagnosis allowing the identification of species of enterococci as well as glycopeptide resistance genes. RESULTS: All the resistant strains were isolated using the enrichment technique. The incidence of GRE (VanA) carriage was 0,55% (two out of 362 patients, two out of 448 isolates) with two Enterococcus faecium VanA. Six Enterococcus gallinarum VanC1 and two Enterococcus casseliflavus VanC2/C3 were also isolated and identified. The main clinics concerned are intensive care and hematology. The two patients with E. faecium VanA had been previously given glycopeptides for 10 days. For three strains, the molecular method allowed to correct prior erroneous results based on rapid identification (RapidID32Strep V2.0). CONCLUSION: The method using direct samples inoculation underestimates real incidence of GRE carriage. The performances of Génotype(®) Enterococcus molecular method, evaluated for other parameters using reference strains and DNA sequencing, offer new possibilities applicable to routine laboratory.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteriological Techniques , Carrier State/microbiology , Drug Resistance, Multiple, Bacterial , Enterococcus/isolation & purification , Glycopeptides/pharmacology , Gram-Positive Bacterial Infections/microbiology , Mass Screening/methods , Reagent Kits, Diagnostic , Aged , Bacterial Proteins/genetics , Carbon-Oxygen Ligases/genetics , Cross Infection/microbiology , Drug Resistance, Multiple, Bacterial/genetics , Enterococcus/classification , Enterococcus/drug effects , Enterococcus/genetics , Enterococcus/growth & development , Feces/microbiology , Female , France , Gram-Positive Bacterial Infections/diagnosis , Hospital Units , Humans , Male , Middle Aged , Peptide Synthases/genetics , Rectum/microbiology , Species Specificity , Vancomycin/pharmacology , Vancomycin Resistance/genetics , Young Adult
7.
Ann Biol Clin (Paris) ; 67(4): 419-24, 2009.
Article in French | MEDLINE | ID: mdl-19654081

ABSTRACT

Cellular morphology has a predominant place in diagnosis of hematological malignancies in spite of flow cytometry, cytogenetic and molecular biology progresses. CellaVisionDM8/96TM is automated microscope and image analysis software which are able to characterize white and red blood cells morphology and to perform platelets counts in peripheral blood smears. Validity of results is always submitted to the cytologist agreement. We routinely analyzed 99 peripheral blood smears, included 9 therapeutic cytopenias, stained with May-Grünwald-Giemsa. DM8/96TM is highly efficient in the cellular identification with great security of identity management and timesaving (30% faster than manual microscopy). Major innovations are the complete slides recording, efficiency on cytopenias processing, education functionalities and the networking ability.


Subject(s)
Automation/methods , Hematologic Neoplasms/blood , Hematology/methods , Autoanalysis , Blood Cells/pathology , Equipment Design , Flow Cytometry , Hematologic Neoplasms/diagnosis , Hematologic Neoplasms/genetics , Hematologic Neoplasms/pathology , Humans , Microscopy/methods , Molecular Biology/methods
8.
Ann Biol Clin (Paris) ; 66(3): 327-31, 2008.
Article in French | MEDLINE | ID: mdl-18558572

ABSTRACT

We report a case of thrombotic thrombocytopenic purpura (TTP) in a 60 years-old woman with Sjogren's syndrome. Symptomatology on admission leads to evoke the diagnosis of TTP. Biological results allow to set the diagnosis. Actually, association of haemolytic anaemia, schizocytes and thrombocytopenia are in favour of TTP. Undetectable ADAMTS 13 activity (below 5%) confirms the diagnosis. In congenital TTP, plasma ADAMTS 13 is absent or severely reduced as a consequence of mutations in the two ADAMTS 13 gene. In acquired TTP, circulating antibodies inhibit plasma ADAMTS 13 activity. In those cases, further biological studies are needed to find a cause of TTP. Follow-up implies standard laboratory tests. Plasma exchanges are progressively tapered after normalization of platelets count.


Subject(s)
Purpura, Thrombotic Thrombocytopenic/diagnosis , Sjogren's Syndrome/complications , ADAM Proteins/immunology , Autoantibodies/blood , Female , Humans , Middle Aged , Purpura, Thrombotic Thrombocytopenic/complications , Purpura, Thrombotic Thrombocytopenic/therapy
9.
Pathol Biol (Paris) ; 56(2): 97-103, 2008 Mar.
Article in French | MEDLINE | ID: mdl-18178332

ABSTRACT

The development of new antithrombotic molecules which induced an inhibition of activated factor X (fondaparinux, Arixtra) shows effectiveness and safety in prevention of thromboembolic disease in surgery, but also in the treatment of the pulmonary embolism and major venous thromboses and acute myocardial infarction. Recent clinical trials show that new anti-Xa inhibitors also have interesting properties in antithrombotic therapy. Fondaparinux could offer new therapeutic possibilities that could simplify the management of patients under anticoagulant treatment.


Subject(s)
Anticoagulants/therapeutic use , Polysaccharides/therapeutic use , Anticoagulants/pharmacology , Blood Coagulation , Cysteine Endopeptidases , Drug Interactions , Fondaparinux , Humans , Neoplasm Proteins/antagonists & inhibitors , Polysaccharides/pharmacology , Thromboembolism/prevention & control
10.
Pathol Biol (Paris) ; 55(8-9): 370-4, 2007 Nov.
Article in French | MEDLINE | ID: mdl-17916415

ABSTRACT

OBJECTIVES: The aim of the present study was to investigate the prevalence Staphylococcus aureus infections carrying Panton-Valentine leukocidin (LPV) genes in our hospital by screening patients that are hospitalised or admitted for consultation, as well as to study the characteristics of these strains and the respectively infected patients. METHODS: A descriptive and retrospective study over the course of a 14 month period was conducted. The isolates of S. aureus were tested for antimicrobial resistance, in which detection of the virulence gene was performed by way of PCR, such as is the case for gene luk-PV which encoding the LPV. The genetic diversity of the strains carrying gene, luk-PV, was determined by way of pulsed-field gel electrophoresis and by the MLVA (Multiple Loci VNTR Analysis; VNTR, Variable Number of Tandem Repeats) method. RESULTS: 7.14% of the S. aureus isolates carried genes for LPV, which are primarily sourced from surgery, emergency, and outpatient consultation services. The nature of the reported infections is often surface, immediately collected, and more rarely deep. Genotyping revealed three principal clones that were gathering 55% of the strains, which in turn highlighted transmission to the nursing staff. COMMENTS: These strains of S. aureus LPV+ have the capacity for diffusion and pathogenicity, which leads to the need to take some specific measures at hospitals: the tracking of the LPV during repeat or deep infections with S. aureus, possibly the search for conveyance and individual measures for the eradication of the strain. Lastly, it is necessary to increase the nursing staff's awareness of the appropriate hygiene measures when they come into contact with these patients.


Subject(s)
Bacterial Toxins/genetics , Cross Infection/epidemiology , Exotoxins/genetics , Leukocidins/genetics , Staphylococcal Infections/epidemiology , Staphylococcus aureus/genetics , Cross Infection/microbiology , Cross Infection/prevention & control , France , Humans , Polymerase Chain Reaction , Retrospective Studies , Species Specificity , Staphylococcal Infections/prevention & control
11.
Ann Fr Anesth Reanim ; 25(11-12): 1135-9, 2006.
Article in French | MEDLINE | ID: mdl-17034986

ABSTRACT

Heparin-induced thrombocytopenia (HIT) is a dangerous complication of heparin therapy caused by an antibody against heparin/Platelet Factor 4 (PF4) complex. HIT complicates about 2% of treatment with unfractionated heparin (UFH). The aim of the study was to determine the incidence of HIT in a burn center and to report four cases in severely burned patients. HIT was documented in 2.8% of burns treated with UFH administered for antithrombotic prophylaxis and in none of burns receiving low molecular weight heparin (LMWH). All HIT cases occurred after extensive deep burns (mean total body surface area or TBSA was 60+/-21%) and three cases had above 75% of burn. We suggest that systemic platelet activation after thermal injury and local production of PF4 in the burn wound could participate to development of HIT. The risk is a late diagnosis since thrombosis clinical detection under burned skin is difficult. HIT appears during the first week of UHF treatment at the same time as a unstable period of fluctuating platelets.


Subject(s)
Burns/therapy , Heparin/adverse effects , Thrombocytopenia/chemically induced , Adult , Burns/classification , Heparin, Low-Molecular-Weight/adverse effects , Humans , Male , Platelet Activation , Thrombocytopenia/epidemiology
12.
Ann Biol Clin (Paris) ; 63(4): 423-7, 2005.
Article in French | MEDLINE | ID: mdl-16061441

ABSTRACT

We report the observation of hepato-splenic and kidneys candidiasis complicating the chemotherapy of a myeloblastic leukemia (LAM5b). Following the lack of effectiveness of a first line treatement, using amphotericine B liposomale and 5-fluorocytosine, implementation of an association of new molecules, a triazole of second generation (voriconazole) and an echinocandine (caspofungine) has allowed a successful result.


Subject(s)
Antifungal Agents/therapeutic use , Candidiasis/drug therapy , Kidney Diseases/microbiology , Leukemia, Myeloid, Acute/microbiology , Liver Diseases/microbiology , Peptides, Cyclic/therapeutic use , Pyrimidines/therapeutic use , Splenic Diseases/microbiology , Triazoles/therapeutic use , Adult , Candidiasis/diagnostic imaging , Caspofungin , Echinocandins , Female , Humans , Lipopeptides , Tomography, X-Ray Computed , Voriconazole
13.
Presse Med ; 34(3): 227-9, 2005 Feb 12.
Article in French | MEDLINE | ID: mdl-15798535

ABSTRACT

INTRODUCTION: Hodgkin's disease with initially predominant bone marrow involvement is observed in 1% of cases. OBSERVATION: A case of Hodgkin's disease with massive bone marrow invasion, manifested by pancytopenia in the context of fever and alteration in general status of health, with little or non superficial peripheral lymph nodes. The bone marrow biopsy revealed extensive myelofibrosis with rare Reed-Sternberg cells. DISCUSSION: This case report is inscribed within the framework of the exceptional massive bone marrow forms of Hodgkin's disease, described by Duhamel et al. in 1979. We believe that metabolic imaging with 18F-FDG positron emission tomography (PET) is a valid examination in orienting diagnosis and post-therapy assessment.


Subject(s)
Bone Marrow Neoplasms/diagnostic imaging , Bone Marrow Neoplasms/pathology , Hodgkin Disease/diagnostic imaging , Hodgkin Disease/pathology , Adult , Fever , Fluorodeoxyglucose F18 , Health Status , Humans , Male , Pancytopenia/etiology , Positron-Emission Tomography , Radiopharmaceuticals
14.
Ann Biol Clin (Paris) ; 63(2): 220-4, 2005.
Article in French | MEDLINE | ID: mdl-15771982

ABSTRACT

A 22-year-old man, who maintains illegally numerous exotic snakes at home (suburbs of Paris), was bitten by one of his Bresilian rattlesnakes, the lance-headed viper Bothrops moojeni, with grade III envenomation. The fibrinogen was less than 0,5 g/L, the prothombin time was 22%, the activated partial thromboplastin time was 94 seconds. The authors discuss the biological and clinical management of this defibrination, due to defibrinogenating proteases (thrombin-like enzymes), present in Bothrops moojeni venom. The patient received 7 vials of an antivenom directed to another crotal, Bothrops lanceolatus. Despite the importance of defibrinogenation, there was only a few clinical evidence of bleeding, according to the literature. The normalization of coagulation studies occured only after day 11. This case-report outlines the danger of the increase of exotic snakes maintained as pet in France and the difficulties to obtain specific antivenoms.


Subject(s)
Animals, Domestic , Antivenins/administration & dosage , Bothrops , Crotalid Venoms , Fibrinogen/analysis , Snake Bites , Adult , Animals , Blood Coagulation Tests , Humans , Injections, Intravenous , Male , Snake Bites/blood , Snake Bites/diagnosis , Snake Bites/therapy , Treatment Outcome
15.
Med Mal Infect ; 34(2): 62-9, 2004 Feb.
Article in French | MEDLINE | ID: mdl-15620016

ABSTRACT

GOAL: This study had for aim to analyze the epidemiology of strains identified in blood cultures (hôpital d'instruction des armées Percy, Clamart, France, hematology unit) to compare the rate of identified micro-organisms with literature data, and to search for a possible correlation between antibiotherapy management and evolution of resistance profiles. MATERIAL AND METHODS: All the micro-organisms (N = 690) collected over seven years (January 1996 to December 2002), from blood cultures of hospitalized patients in conventional and sterile sector were studied. RESULTS: Gram positive cocci rate (GPC) was 62.6% and Gram negative bacilli (GNB) 31.3%. Evolution in time showed a decrease of GPC and an increase of GNB, notably the non fermenting Gram negative bacilli, leading to an equal rate by 2001-2002. The most frequently identified species were Staphylococcus epidermidis (36.4%), Escherichia coli (8.7%), Pseudomonas aeruginosa (6.8%), and Staphylococcus aureus (4.9%). The rate of methicillin-resistant staphylococci was 63.6%. Fifty-five percent of E. coli strains had a penicillinase phenotype. Pseudomonas aeruginosa resistance was 8.5, 8.5, 6.4 and 8.5%, respectively for ceftazidime, piperacillin-tazobactam, imipenem, and amikacin. CONCLUSION: This study showed a tendency to inversion of former bacteremia epidemiology with increasing negative Gram bacilli. It justifies the antibiotherapy protocols adopted in the hematology unit.


Subject(s)
Bacteremia/epidemiology , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Drug Resistance, Bacterial , Epidemiologic Studies , France , Health Surveys , Hospitals/statistics & numerical data , Humans , Phenotype
16.
Ann Biol Clin (Paris) ; 61(1): 84-7, 2003.
Article in French | MEDLINE | ID: mdl-12604391

ABSTRACT

Non traumatic coma in diabete mellitus has two origins : hypo- or hyperglycemia. Coma with hyperglycemia can be due to ketoacidosis, hyperosmolar state or lactic acidosis. The present observation reports on a type 2 diabete mellitus patient presenting with a coma while the patient was on metformin and glibenclamide treatment. On admission, biologicals tests showed major acidosis, hyperglycemia and hyperosmolarity. No metformine accumulation was demonstrated by analytical measure. In this case, the association of hyperosmolar state and metabolic acidosis prove the difficulty of the differential diagnosis.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Diabetic Coma/diagnosis , Hypoglycemic Agents/adverse effects , Metformin/adverse effects , Aged , Diagnosis, Differential , Drug Therapy, Combination , Glyburide/adverse effects , Humans , Hyperglycemia , Male
17.
Pathol Biol (Paris) ; 49(1): 23-32, 2001 Feb.
Article in French | MEDLINE | ID: mdl-11265220

ABSTRACT

The authors studied seven automatic washer disinfectors for flexible endoscopes with two methods. The first method, a microdilution method, studied the bactericidal activity of the seven disinfectants against 21 strains: four reference strains, 14 hospital strains reported in the literature as nosocomial strains responsible for infections transmitted by flexible endoscopes and three vancomycin-resistant Enterococci. The ability of the seven automatic washer disinfectors to decontaminate flexible endoscopes following inoculation with four reference strains was studied with the second method. There were three kinds of results: the results of three automatic washer disinfectors in conformity with both methods; the results of three automatic washer disinfectors conformity with 1 method only; the results of one automatic washer disinfector without conformity with any methods. Both methods should be used for evaluation of automatic washer disinfector. Then, these results emphasize the necessity to modify the use of disinfectants and/or the systems of some automatic washer disinfectors.


Subject(s)
Anti-Bacterial Agents , Disinfectants , Disinfection/instrumentation , Disinfection/methods , Endoscopes , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Disinfectants/pharmacology , Equipment Contamination/prevention & control
18.
Pathol Biol (Paris) ; 47(10): 1053-9, 1999 Dec.
Article in French | MEDLINE | ID: mdl-10674258

ABSTRACT

The increasing hospital-to-hospital transmission of multiple drug-resistant bacteria is a major concern for bacteriology laboratories involved in nosocomial infection control. The interlaboratory reproducibility of pulsed-field gel electrophoresis (PFGE) for Pseudomonas aeruginosa typing was evaluated by asking four hospital laboratories (two in Lyon, one in Brest, and one in Marseille) to study 11 P. aeruginosa isolates, some of which were epidemiologically related, and the reference strain ATCC 27853. Two laboratories used the Genepath system, one the Chef DR II, system, and one the Chef Mapper system, Bio-Rad, restriction/Spe I. Profiles were read visually and by computerized comparison of restriction band molecular weights (Taxotron, software, PAD Grimont, Pasteur Institute, Paris, France). These two methods led to similar epidemiological conclusions. However, centralization of the data showed poor center-to-center reproducibility due to inadequate standardization of the procedure.


Subject(s)
Electrophoresis, Gel, Pulsed-Field/standards , Laboratories/standards , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/classification , Electrophoresis, Gel, Pulsed-Field/methods , France , Genetic Linkage , Genotype , Humans , Phylogeny , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification , Quality Assurance, Health Care , Reproducibility of Results
19.
Presse Med ; 27(28): 1427-9, 1998 Sep 26.
Article in French | MEDLINE | ID: mdl-9793039

ABSTRACT

OBJECTIVE: Assess the prevalence of asymptomatic carriage of vancomycin-resistant Enterococci in a population of healthy young French subjects. METHODS: Stool samples obtained from 100 persons living in south-eastern France (20 sampling sites) were directly seeded on enriched selective media containing 6 mg/l vancomycin. Bacterial species and their resistant gene were identified with classical methods and multiplex genomic amplification. RESULTS: The incidence of asymptomatic carriage was 17% with a homogeneous geographic distribution of the resistant strains. Nine Enterococcus faecium van A strains and 8 E. gallinarum van C1 strains were isolated. CONCLUSION: These findings demonstrate carriage of vancomycin-resistant Enterococci in a population of young ambulatory subjects in France. The incidence observed was much higher than in an earlier study conducted in France. These results might be explained by a much more sensitive detection technique. Care should be taken to avoid dissemination in hospital settings.


Subject(s)
Enterococcus/drug effects , Vancomycin/pharmacology , Adult , Ambulatory Care/statistics & numerical data , Drug Resistance, Microbial , Enterococcus faecium/drug effects , Feces/microbiology , France , Humans , Male , Microbial Sensitivity Tests , Species Specificity
20.
Pathol Biol (Paris) ; 46(6): 369-74, 1998 Jun.
Article in French | MEDLINE | ID: mdl-9769863

ABSTRACT

In 1996-1997 a multicentre study was carried out on 450 Streptococcus pneumoniae strains to compare the MICs and susceptibility categories obtained with the Etest (AB Biodisk) used under routine conditions in 22 hospital laboratories in the Rhône-Alpes region, France, with those obtained by the reference technique of agar dilution performed in a single coordinating centre. Each laboratory detected penicillin resistant pneumococci (PRP) by the oxacillin disk method (1 microgram and 5 micrograms) and determined the MICs of penicillin G (PG), amoxycillin (AMX) and cefotaxime (CTX) by the Etest. All the PRP strains were collected in the coordinating centre where MICs were carried out. The strains were classified as susceptible (S), intermediate (I) and resistant (R) according to the CASFM criteria (Comité de l'Antibiogramme de la Société Française de Microbiologie). The concordance results based on susceptibility categories are as follows: PG = 67.6%, AMX = 63.6%, CTX = 71.5%. Minor errors are as follows: PG = 31.2%, AMX = 36%, CTX = 28.5%. Major and very major errors are rare (0% to 0.6%). Agreement within 1 log2 dilution was obtained for about 80% of the strains. The minor errors results from strains clustering near the breakpoints 1 mg/l (PG) and 0.5 mg/l (AMX, CTX), and from practical difficulties in routine use of the Etest. These discrepancies may result in severe therapeutic problems. This study confirms the limits of the Etest. The authors insist on standardization and rigorous use of the Etest under routine conditions.


Subject(s)
Amoxicillin/pharmacology , Cefotaxime/pharmacology , Cephalosporin Resistance , Microbial Sensitivity Tests/methods , Penicillin G/pharmacology , Penicillin Resistance , Streptococcus pneumoniae/drug effects , Culture Media , Diffusion , Evaluation Studies as Topic , False Negative Reactions , False Positive Reactions , Microbial Sensitivity Tests/standards , Quality Control , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL
...